157 related articles for article (PubMed ID: 34282850)
1. Primary undifferentiated pleomorphic sarcoma in oral-maxillary area: retrospective study and molecular analysis.
You Y; Shi R; Dai M; Du Z; Tian Z; Xu G; Wang L; Wang Y; Xiao M
Histol Histopathol; 2021 Aug; 36(8):889-898. PubMed ID: 34282850
[TBL] [Abstract][Full Text] [Related]
2. Impact of histological subtype on radiological and pathological response after neoadjuvant radiotherapy in soft tissue sarcoma.
Allignet B; Meurgey A; Bouhamama A; Karanian M; Meeus P; Vaz G; Gouin F; Moncharmont C; Prapant S; Waissi W; Sunyach MP
Eur J Surg Oncol; 2021 Dec; 47(12):2995-3003. PubMed ID: 34281731
[TBL] [Abstract][Full Text] [Related]
3. Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets.
Cui Y; Han L; Shang J; Fang W; Zhao M; Chen D; Liu H
Hum Pathol; 2022 May; 123():113-122. PubMed ID: 35181378
[TBL] [Abstract][Full Text] [Related]
4. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
[TBL] [Abstract][Full Text] [Related]
5. High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies.
Toulmonde M; Lucchesi C; Verbeke S; Crombe A; Adam J; Geneste D; Chaire V; Laroche-Clary A; Perret R; Bertucci F; Bertolo F; Bianchini L; Dadone-Montaudie B; Hembrough T; Sweet S; Kim YJ; Cecchi F; Le Loarer F; Italiano A
EBioMedicine; 2020 Dec; 62():103131. PubMed ID: 33254023
[TBL] [Abstract][Full Text] [Related]
6. The clinical outcomes of undifferentiated pleomorphic sarcoma (UPS): A single-centre experience of two decades with the assessment of PD-L1 expressions.
Lee K; Song JS; Kim JE; Kim W; Song SY; Lee MH; Chung HW; Cho KJ; Lee JS; Ahn JH
Eur J Surg Oncol; 2020 Jul; 46(7):1287-1293. PubMed ID: 32127249
[TBL] [Abstract][Full Text] [Related]
7. A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report.
Zhou N; Schäfer R; Li T; Fang M; Liu L
BMC Cancer; 2018 Aug; 18(1):842. PubMed ID: 30134855
[TBL] [Abstract][Full Text] [Related]
8. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F
J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
Roland CL; May CD; Watson KL; Al Sannaa GA; Dineen SP; Feig R; Landers S; Ingram DR; Wang WL; Guadagnolo BA; Feig B; Hunt KK; Cormier JN; Lazar AJ; Torres KE
Ann Surg Oncol; 2016 Jul; 23(7):2220-8. PubMed ID: 26847678
[TBL] [Abstract][Full Text] [Related]
10. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma.
Wu-Chou YH; Hsieh CH; Liao CT; Lin YT; Fan WL; Yang CH
Pathol Res Pract; 2021 Jul; 223():153474. PubMed ID: 33993060
[TBL] [Abstract][Full Text] [Related]
11. Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.
Lewin J; Garg S; Lau BY; Dickson BC; Traub F; Gokgoz N; Griffin AM; Ferguson PC; Andrulis IL; Sim HW; Kamel-Reid S; Stockley TL; Siu LL; Wunder JS; Razak ARA
Int J Cancer; 2018 Jan; 142(1):57-65. PubMed ID: 28891048
[TBL] [Abstract][Full Text] [Related]
12. Secondary undifferentiated pleomorphic sarcoma of the mandible in a HIV patient who underwent radiotherapy for oral carcinoma.
Lombardi N; Varoni EM; Bazzacchi R; Moneghini L; Lodi G
Spec Care Dentist; 2021 May; 41(3):417-422. PubMed ID: 33543781
[TBL] [Abstract][Full Text] [Related]
13. Undifferentiated pleomorphic sarcoma of the breast with neoplastic fever: case report and genomic characterization.
Gambichler T; Horny K; Mentzel T; Stricker I; Tannapfel A; Scheel CH; Behle B; Quast DR; Lee YP; Stücker M; Susok L; Becker JC
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1465-1471. PubMed ID: 35501497
[TBL] [Abstract][Full Text] [Related]
14. Tail of Superficial Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma After Preoperative Radiotherapy.
Imanishi J; Slavin J; Pianta M; Jackett L; Ngan SY; Tanaka T; Charoenlap C; DI Bella C; Choong PF
Anticancer Res; 2016 May; 36(5):2339-44. PubMed ID: 27127141
[TBL] [Abstract][Full Text] [Related]
15. RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas.
Serrano C; Romagosa C; Hernández-Losa J; Simonetti S; Valverde C; Moliné T; Somoza R; Pérez M; Vélez R; Vergés R; Domínguez R; Carles J; Ramón Y Cajal S
Cancer; 2016 Jan; 122(1):99-107. PubMed ID: 26479291
[TBL] [Abstract][Full Text] [Related]
16. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.
Vodanovich DA; Spelman T; May D; Slavin J; Choong PFM
ANZ J Surg; 2019 Sep; 89(9):1045-1050. PubMed ID: 31364245
[TBL] [Abstract][Full Text] [Related]
17. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Fusion Transcripts in Undifferentiated Pleomorphic Sarcomas by Transcriptome Sequencing.
Zheng B; Zhang S; Cai W; Wang J; Wang T; Tang N; Shi Y; Luo X; Yan W
Cancer Genomics Proteomics; 2019; 16(5):399-408. PubMed ID: 31467233
[TBL] [Abstract][Full Text] [Related]
19. Mandibular undifferentiated pleomorphic sarcoma: Molecular analysis of a primary cell population.
Amm HM; DeVilliers P; Srivastava AR; Diniz MG; Siegal GP; MacDougall M
Clin Exp Dent Res; 2020 Oct; 6(5):495-505. PubMed ID: 32652895
[TBL] [Abstract][Full Text] [Related]
20. Undifferentiated pleomorphic sarcoma with co-existence of KRAS/PIK3CA mutations.
Li B; Li L; Li X; Wang Y; Xie Y; Liu C; Li F
Int J Clin Exp Pathol; 2015; 8(7):8563-7. PubMed ID: 26339434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
